Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$1.37 – $2.25
32% from low
Exchange
OTC Link
OS
INNATE PHARMA
No one on the platform currently holds IPHYF.
No tracked institution reports a position in IPHYF as of their last filing.
No one on the platform has traded IPHYF yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $20M | +37.1% | $-0.39 | $-1.82–$0.06 | — | 1 |
| 2027 | $32M | +56.3% | $-0.48 | $-2.24–$0.08 | — | 1 |
| 2028 | $51M | +59.9% | $-0.65 | $-3.02–$0.10 | — | 1 |
| 2029 | $263M | +417.7% | $0.56 | $-0.09–$2.61 | 3.0× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 3 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-03-26 | $-0.35 | $-0.35 | +0.0% |
| 2025-09-17 | $-0.33 | $-0.29 | +12.4% |
| 2025-05-12 | $-0.26 | $-0.32 | -19.6% |
| 2024-11-13 | $-0.30 | $-0.33 | -9.8% |
| 2024-05-14 | $-0.45 | $-0.13 | +71.5% |
| 2023-09-14 | $0.09 | $0.02 | -74.4% |
| 2023-03-23 | $-0.42 | $-0.87 | -107.3% |
| 2022-11-14 | $0.39 |
| $0.08 |
| -79.2% |
| $68M |
| — |
| JWCTFJW (Cayman) Therapeutics Co. Ltd | $0.20 | +0.00% | $84M | — |
| KNTPFKintor Pharmaceutical Limited | $0.24 | +0.00% | $112M | — |
Source: Financial Modeling Prep · peers by sector/industry